CN Patent

CN116410228B — 一种抗冠状病毒核苷类化合物的制备方法及其应用

Assigned to Guoqing Biomedical Shanghai Co ltd · Expires 2025-10-31 · 1y expired

What this patent protects

本发明公开了一种抗冠状病毒核苷类化合物的制备方法及其应用，其结构式为： ；药效试验结果显示在目前高浓度背景下，试验样品在0.04uM浓度下仍具有一定的抗病毒活性，与已上市对照药莫努匹拉韦抗病毒活性相当，具备进一步研究的价值。

USPTO Abstract

本发明公开了一种抗冠状病毒核苷类化合物的制备方法及其应用，其结构式为： ；药效试验结果显示在目前高浓度背景下，试验样品在0.04uM浓度下仍具有一定的抗病毒活性，与已上市对照药莫努匹拉韦抗病毒活性相当，具备进一步研究的价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN116410228B
Jurisdiction
CN
Classification
—
Expires
2025-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Guoqing Biomedical Shanghai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.